Drugs for MRSA with reduced susceptibility to vancomycin

Mark Abramowicz, Gianna Zuccotti, Jean Marie Pflomm, Susan M. Daron, Blaine M. Houst, Corinne E. Zanone, Carl W. Bazil, Vanessa K. Dalton, Eric J. Epstein, Sandip K. Mukherjee, Jordan W. Smoller, Jules Hirsch, David N. Juurlink, Richard B. Kim, Gerald L. Mandell, Hans Meinertz, Dan M. Roden, F. Estelle R. Simons, Neal H. Steigbigel, Donna GoodsteinAmy Faucard, Cynthia Macapagal Covey, Lauren K. Schwartz, Manouchkathe Cassagnol, Susie Wong, Liz Donohue, Cheryl Brown, Gene Carbona, Cristine Romatowski, Joanne F. Valentino, Yosef Wissner-Levy

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Number of pages1
JournalMedical Letter on Drugs and Therapeutics
Volume51
Issue number1311
StatePublished - May 4 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Abramowicz, M., Zuccotti, G., Pflomm, J. M., Daron, S. M., Houst, B. M., Zanone, C. E., Bazil, C. W., Dalton, V. K., Epstein, E. J., Mukherjee, S. K., Smoller, J. W., Hirsch, J., Juurlink, D. N., Kim, R. B., Mandell, G. L., Meinertz, H., Roden, D. M., Simons, F. E. R., Steigbigel, N. H., ... Wissner-Levy, Y. (2009). Drugs for MRSA with reduced susceptibility to vancomycin. Medical Letter on Drugs and Therapeutics, 51(1311).